Cooled Ablation System Treats Painful Spine Metastases
By HospiMedica International staff writers Posted on 07 Feb 2016 |
A new ablation system uses water-cooled radiofrequency (RF) probes to reduce patient pain when ablating metastatic spinal tumors.
The OsteoCool RF Ablation System is intended for palliative treatment in spinal procedures by ablation of metastatic malignant lesions present in a vertebral body. The ablation system works together with the Baylis Pain Management Generator-TD (PMG-TD) to deliver the RF energy to the target ablation site. To cool the probes during the procedure, a tube kit connected to a pump unit is used to circulate water internally. A battery operated thermocouple monitor connects to a port on the PMG-TD to display the temperature detected.
The system offers simultaneous, dual-probe capabilities, with the 17-gauge, bipolar probes available in three lengths which may be used through a variety of cannula sizes. Since two ablation probes can be used simultaneously, the system supports a variety of scenarios that accommodate unique patient and procedural needs. The OsteoCool RF Ablation System was developed by Baylis Medical (Montreal, QC, Canada), which sold the technology and intellectual property to Medtronic (Dublin, Ireland) after receiving marketing approval from the US Food and Drug Administration (FDA).
“The OsteoCool System expands our pain therapies portfolio. Our customers treat patients with balloon kyphoplasty who also have painful spinal metastases; the OsteoCool system gives physicians a way to treat that pain in a single procedure with a familiar, minimally invasive technique,” said Julie Foster, general manager and vice president of pain therapies in the Medtronic neuromodulation division.
“The most common complaint associated with spine metastases is pain; it's often progressive and significantly reduces the patient's quality of life,” said interventional radiologist Sandeep Bagla, MD, of the Vascular Institute of Virginia (Woodbridge, VA, USA). “With the OsteoCool system, I can now ablate the patient's painful tumor with a reproducible procedure that's appropriate for their unique anatomy.”
In November 2105, Medtronic received expanded indications for Kyphon Xpede bone cement, which now includes clearance for the treatment osteolytic lesions. Where indicated, the OsteoCool bone access kit can be used for a subsequent, physician-directed procedure such as cementoplasty.
Related Links:
Baylis Medical
Medtronic
The OsteoCool RF Ablation System is intended for palliative treatment in spinal procedures by ablation of metastatic malignant lesions present in a vertebral body. The ablation system works together with the Baylis Pain Management Generator-TD (PMG-TD) to deliver the RF energy to the target ablation site. To cool the probes during the procedure, a tube kit connected to a pump unit is used to circulate water internally. A battery operated thermocouple monitor connects to a port on the PMG-TD to display the temperature detected.
The system offers simultaneous, dual-probe capabilities, with the 17-gauge, bipolar probes available in three lengths which may be used through a variety of cannula sizes. Since two ablation probes can be used simultaneously, the system supports a variety of scenarios that accommodate unique patient and procedural needs. The OsteoCool RF Ablation System was developed by Baylis Medical (Montreal, QC, Canada), which sold the technology and intellectual property to Medtronic (Dublin, Ireland) after receiving marketing approval from the US Food and Drug Administration (FDA).
“The OsteoCool System expands our pain therapies portfolio. Our customers treat patients with balloon kyphoplasty who also have painful spinal metastases; the OsteoCool system gives physicians a way to treat that pain in a single procedure with a familiar, minimally invasive technique,” said Julie Foster, general manager and vice president of pain therapies in the Medtronic neuromodulation division.
“The most common complaint associated with spine metastases is pain; it's often progressive and significantly reduces the patient's quality of life,” said interventional radiologist Sandeep Bagla, MD, of the Vascular Institute of Virginia (Woodbridge, VA, USA). “With the OsteoCool system, I can now ablate the patient's painful tumor with a reproducible procedure that's appropriate for their unique anatomy.”
In November 2105, Medtronic received expanded indications for Kyphon Xpede bone cement, which now includes clearance for the treatment osteolytic lesions. Where indicated, the OsteoCool bone access kit can be used for a subsequent, physician-directed procedure such as cementoplasty.
Related Links:
Baylis Medical
Medtronic
Read the full article by registering today, it's FREE!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
- Free digital version edition of HospiMedica International sent by email on regular basis
- Free print version of HospiMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of HospiMedica International in digital format
- Free HospiMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Critical Care News
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration